Secreted effectors of Toxoplasma gondii bradyzoites

弓形虫缓殖子的分泌效应子

基本信息

项目摘要

Project Summary/Abstract Toxoplasma gondii is an obligate intracellular parasite of the phylum Apicomplexa, a diverse group of parasites that cause various diseases in humans, such as malaria and cryptosporidiosis. T. gondii is ubiquitous worldwide, estimated to infect one-third of the human population, and is a public health concern in immunocompromised and pregnant individuals. The acute phase of infection is characterized by the tachyzoite, a fast-replicating life stage that disseminates throughout the body of a warm-blooded host. The chronic phase of infection is characterized by the bradyzoite, a slowly- replicating life stage which encysts in muscle and neural tissue via the formation of a cyst wall within a host cell. Bradyzoite biology is poorly understood; the exact composition of the cyst wall, how bradyzoites persist within host cells indefinitely, or how bradyzoites manipulate host cell function is unknown. Previous studies have demonstrated the secretion of several protein effectors by tachyzoites into their host cells across the parasitophorous vacuole, the site where parasites replicate within host cells. These include the proteins GRA16, GRA24, GRA28, and TgIST, most of which have been shown to localize to the host cell nucleus and directly interact with host cell proteins, altering host cell signaling cascades and transcription. Whether these proteins, or other unidentified secreted proteins, cross the cyst wall and enter bradyzoite infected host cells has not been previously explored. In this proposal, the first aim will be to determine the localization of GRA16, GRA24, GRA28, and TgIST after bradyzoite differentiation in vitro by epitope tagging secreted effectors at their endogenous loci and in vivo in the mouse brain using an optical clearing approach. In the second aim, the role of TgIST in bradyzoite infected cells will be investigated by knocking out and complementing the TgIST gene in the parasite and subsequently determining the inhibition of STAT1 mediated transcription in bradyzoite infected host cells. In the third aim, proximity-based biotin labeling enzymes will be fused to MYR1, a protein implicated in parasite protein export into the host cell. This will allow the identification of secreted effectors during the bradyzoite stage by mass spectrometry of biotinylated proteins following validation of positive hits. The discovery of secreted effectors by bradyzoites into host cells would challenge a paradigm in the field of Toxoplasma research, where the bradyzoite has classically been viewed as an inert but transmissible stage of the parasite. This will lead to further studies on understanding how bradyzoites alter host cell function and maintain persistency in their hosts.
项目总结/摘要 弓形虫是一种专性细胞内寄生虫的门顶复门,一个多样化的群体, 引起人类各种疾病的寄生虫,如疟疾和隐孢子虫病。T.弓形虫是 在世界范围内普遍存在,估计感染三分之一的人口,是一个公共卫生 免疫功能低下和怀孕的人的关注。感染的急性期是 以速殖子为特征,速殖子是一种快速复制的生命阶段, 一个热血的宿主感染的慢性期以缓殖子为特征,缓殖子是一种缓慢的- 通过在肌肉和神经组织内形成囊壁而包囊的复制生命阶段 宿主细胞缓殖子生物学知之甚少;囊壁的确切组成,如何 缓殖子在宿主细胞内无限期地存在,或者缓殖子如何操纵宿主细胞功能, 未知以前的研究已经证明了几种蛋白质效应物的分泌, 速殖子穿过寄生虫的空泡进入宿主细胞,空泡是寄生虫复制的地方 在宿主细胞内。这些包括蛋白质GRA 16、GRA 24、GRA 28和TgIST,其中大多数具有 已被证明定位于宿主细胞核,并直接与宿主细胞蛋白相互作用,改变 宿主细胞信号级联和转录。无论是这些蛋白质,还是其他未知的分泌物 蛋白质,穿过囊壁并进入缓殖子感染的宿主细胞,以前没有 探讨了在这个建议中,第一个目标将是确定GRA 16,GRA 24, GRA 28和TgIST在通过表位标记分泌的效应子体外分化后, 它们的内源性位点和在小鼠脑中的体内使用光学清除方法。在 第二个目的,将通过敲除和转染研究TgIST在缓殖子感染细胞中的作用。 补充寄生虫中的TgIST基因,随后确定STAT 1的抑制 在缓殖子感染的宿主细胞中介导转录。在第三个目标中,基于邻近的生物素 标记酶将与MYR 1融合,MYR 1是一种与寄生虫蛋白质输出到宿主中有关的蛋白质 cell.这将允许通过质量鉴定缓殖子阶段期间分泌的效应物 在确认阳性命中后,生物素化蛋白的光谱分析。秘密的发现 缓殖子进入宿主细胞的效应器将挑战弓形虫领域的范式 研究,其中缓殖子已被经典地视为一个惰性的,但传输阶段的 寄生虫这将导致进一步的研究,了解缓殖子如何改变宿主细胞的功能, 在它们的宿主中保持持久性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joshua Alexander Mayoral其他文献

Joshua Alexander Mayoral的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joshua Alexander Mayoral', 18)}}的其他基金

Secreted effectors of Toxoplasma gondii bradyzoites
弓形虫缓殖子的分泌效应子
  • 批准号:
    9762554
  • 财政年份:
    2018
  • 资助金额:
    $ 2.66万
  • 项目类别:

相似国自然基金

稻瘟病菌多靶点效应蛋白(MAX-effectors)的人工设计及其与水稻受体互作的结构基础
  • 批准号:
    31901870
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

MARVEL-ous Extracellular vesicles carry RXLR effectors into host plant cells
MARVEL-ous 细胞外囊泡携带 RXLR 效应子进入宿主植物细胞
  • 批准号:
    BB/Y002067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.66万
  • 项目类别:
    Research Grant
MARVEL-ous extracellular vesicles carry RXLR effectors into host plant cells
MARVEL-ous细胞外囊泡携带RXLR效应子进入宿主植物细胞
  • 批准号:
    BB/Y002393/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.66万
  • 项目类别:
    Research Grant
Collaborative Research: How to manipulate a plant? Testing for conserved effectors and plant responses in gall induction and growth using a multi-species comparative approach.
合作研究:如何操纵植物?
  • 批准号:
    2305880
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
    Standard Grant
DNA methylation and effectors associated with lifestyle diseases study
DNA甲基化和与生活方式疾病相关的效应物研究
  • 批准号:
    23K16331
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exploring the origins of root-nodule symbiosis: Functional analysis of rhizobial effectors governing primitive rhizobial symbiosis
探索根瘤共生的起源:控制原始根瘤菌共生的根瘤菌效应子的功能分析
  • 批准号:
    23KK0108
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Chlamydia type III effectors affecting the host actin-based cytoskeleton
III 型衣原体效应子影响宿主肌动蛋白细胞骨架
  • 批准号:
    10632935
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
PARP1 and PARylation as novel effectors of gut inflammation
PARP1 和 PARylation 作为肠道炎症的新型效应物
  • 批准号:
    10679646
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
Stenotrophomonas maltophilia TfcA and TfcB: Antibacterial T4SS effectors from an emerging human pathogen
嗜麦芽寡养单胞菌 TfcA 和 TfcB:来自新兴人类病原体的抗菌 T4SS 效应子
  • 批准号:
    10661253
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
Using Bacterial Effectors to Uncover Innate Immune Mechanisms Restricting Viral Replication in Bat Cells
利用细菌效应器揭示蝙蝠细胞中限制病毒复制的先天免疫机制
  • 批准号:
    10592024
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
Oxidized lipids and microvesicle particles as effectors for chemical threats to skin
氧化脂质和微泡颗粒作为皮肤化学威胁的效应器
  • 批准号:
    10648739
  • 财政年份:
    2023
  • 资助金额:
    $ 2.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了